DRRX - DURECT gets FDA breakthrough therapy status for larsucosterol
2024-05-21 10:10:08 ET
More on DURECT
- DURECT Corporation (DRRX) Q1 2024 Earnings Call Transcript
- DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript
- DURECT Q1 2024 Earnings Preview
- DURECT and Charles River enter agreement for alzet in U.S., Canada
- Seeking Alpha’s Quant Rating on DURECT